Emerging Technologies in Transfusion Medicine
Program Code: 417-TC
Tuesday, October 26, 2004
2:00 PM to 3:30 PM (ET)

SPEAKERS
James Bradner, MD, Dana Farber Cancer Institute
Don Siegel, MD, PhD, Department of Pathology, University of Pennsylvania
Zbigniew Szczepiorkowski, MD, PhD, FCAP, Dartmouth-Hitchcock Medical Center

DESCRIPTION
Some of the technologies discovered and developed during the explosion in molecular and cell biology in the past 15 years are making the transition from the basic research arena into the clinical laboratories and even into the clinic itself. During this short topic, experts will review the use of three of these new technologies. The focus of each presentation will be on the clinical application of these emerging technologies in transfusion medicine.

OBJECTIVES

• Discuss the use of the monoclonal B-cell antibody, Rituximab, in the treatment of B-cell disorders including lymphomas and immune thrombocytopenic purpura
• Explain the basis for phage display techniques and how they are being used to develop diagnostic and therapeutic tools
• Describe the ex-vivo sensitization of dendritic cells to tumor antigens and their use as anti-tumor "vaccines"

AUDIENCE
Physicians, Scientists, Technologists, Nurses, Managers/Supervisors

PROGRAM LEVEL
Advanced